2834 – Page 197 – China Stock Advice

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: Skystar to Present at Upcoming Investor Conferences XI’AN,

[Skystar to Present at Upcoming Investor Conferences XI'AN, CHINA — March 2, 2010 — Skystar Bio-Pharmaceutical Company · Rodman & Renshaw Annual China Investment Conference at The Regent Hotel in Beijing, China on March 8, 2010 at 2:25pm Beijing time (1:25am Eastern time); · nd Roth 22 http://www.ir-site.com/skystar/events.asp An audio and slide webcast of each presentation will be available under]

By info| 2016-03-01T06:36:00+00:00 March 2nd, 2010|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: 0001076939, 2010-03-02, 2834, 8-K, PHARMACEUTICAL PREPARATIONS, SKBI|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: (Original Filing)

[Skystar to Present at Upcoming Investornferences XI'AN, CHINA March 2, 2010ystar Bio-Pharmaceuticalmpany Rodman & Renshaw Annual China Investmentnference at The Regent Hotel in Beijing, China on March 8, 2010 at 2:25pm Beijing time (1:25am Eastern time); nd Roth 22 http://www.ir-site.com/skystar/events.asp An audio and slide webcast of each presentation will be available under the Events and]

By info| 2016-02-05T04:36:42+00:00 March 2nd, 2010|Categories: Chinese Stocks, SEC Original, SKBI|Tags: 0001076939, 2010-03-02, 2834, 8-K, PHARMACEUTICAL PREPARATIONS, SKBI|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: Skystar to Present at Upcoming Investornferences XI’AN, CHINA

[Skystar to Present at Upcoming Investornferences XI'AN, CHINA March 2, 2010ystar Bio-Pharmaceuticalmpany Rodman & Renshaw Annual China Investmentnference at The Regent Hotel in Beijing, China on March 8, 2010 at 2:25pm Beijing time (1:25am Eastern time); nd Roth 22 http://www.ir-site.com/skystar/events.asp An audio and slide webcast of each presentation will be available under the Events and]

By info| 2016-02-05T04:37:30+00:00 March 2nd, 2010|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: 0001076939, 2010-03-02, 2834, 8-K, PHARMACEUTICAL PREPARATIONS, SKBI|0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: Biostar Pharmaceuticals, Inc. Announces 2010 Guidance: Revenues of

[Biostar Pharmaceuticals, Inc. Announces 2010 Guidance: Revenues of $69 to $71 million and Net Income $16.2 to $17 million XIANYANG, China, March 1, 2010 (Xinhua-PRNewswire-FirstCall) Biostar forecasts revenues of $69.0 to $71.0 million with net income of $16.2 million to $17 million, excluding any non-cash charges. Management anticipates sales of its flagship product, Xin Aoxing, will represent approximately 68% to]

By info| 2016-03-03T14:48:39+00:00 March 1st, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: 0001418133, 2010-03-01, 2834, 8-K, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[Biostar Pharmaceuticals, Inc. Announces 2010 Guidance: Revenues of $69 to $71 million and Net Income $16.2 to $17 million XIANYANG, China, March 1, 2010 (Xinhua-PRNewswire-FirstCall) Biostar forecasts revenues of $69.0 to $71.0 million with net income of $16.2 million to $17 million, excluding any non-cash charges. Management anticipates sales of its flagship product, Xin Aoxing, will represent approximately 68% to]

By info| 2016-03-03T14:47:22+00:00 March 1st, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: 0001418133, 2010-03-01, 2834, 8-K, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[Biostar Pharmaceuticals, Announces 2010 Guidance: Revenues of $69 to $71 million and Netome $16.2 to $17 million XIANYANG, China, March 1, 2010 (Xinhua-PRNewswire-FirstCall) Biostar forecasts revenues of $69.0 to $71.0 million with netome of $16.2 million to $17 million, excluding any non-cash charges. Management anticipatesles of its flagship product, Xin Aoxing, will represent approximately 68%]

By info| 2016-02-07T17:38:37+00:00 March 1st, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: 0001418133, 2010-03-01, 2834, 8-K, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: Biostar Pharmaceuticals, Announces 2010 Guidance: Revenues of $69

[Biostar Pharmaceuticals, Announces 2010 Guidance: Revenues of $69 to $71 million and Netome $16.2 to $17 million XIANYANG, China, March 1, 2010 (Xinhua-PRNewswire-FirstCall) Biostar forecasts revenues of $69.0 to $71.0 million with netome of $16.2 million to $17 million, excluding any non-cash charges. Management anticipatesles of its flagship product, Xin Aoxing, will represent approximately 68%]

By info| 2016-02-07T17:39:08+00:00 March 1st, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: 0001418133, 2010-03-01, 2834, 8-K, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[Biostar Pharmaceuticals, Inc. Provides Preliminary 2009 Results: Revenue of $52 - $54 Million and Operating Income of $16 – $17 million excluding non-cash charges XIANYANG, China, February 25, 2010 (Xinhua-PRNewswire-FirstCall) Biostar expects to report gross margin for 2009 of approximately 71%, an increase of 1200 basis-points compared to 59% in 2008. Management anticipates unaudited operating income, excluding non-cash charges, of]

By info| 2016-03-03T14:49:57+00:00 February 25th, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: 0001418133, 2010-02-25, 2834, 8-K, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: Biostar Pharmaceuticals, Inc. Provides Preliminary 2009 Results: Revenue

[Biostar Pharmaceuticals, Inc. Provides Preliminary 2009 Results: Revenue of $52 - $54 Million and Operating Income of $16 – $17 million excluding non-cash charges XIANYANG, China, February 25, 2010 (Xinhua-PRNewswire-FirstCall) Biostar expects to report gross margin for 2009 of approximately 71%, an increase of 1200 basis-points compared to 59% in 2008. Management anticipates unaudited operating income, excluding non-cash charges, of]

By info| 2016-03-03T14:50:50+00:00 February 25th, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: 0001418133, 2010-02-25, 2834, 8-K, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[Biostar Pharmaceuticals, Provides Preliminary 2009 Results: Revenue of $52 - $54 Million and Operatingome of $16 $17 million excluding non-cash charges XIANYANG, China, February 25, 2010 (Xinhua-PRNewswire-FirstCall) Biostar expects to report gross margin for 2009 of approximately 71%, anrease of 1200 basis-pointsmpared to 59% in 2008. Management anticipates unaudited operatingome, excluding non-cash charges, of approximately]

By info| 2016-02-07T17:40:08+00:00 February 25th, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: 0001418133, 2010-02-25, 2834, 8-K, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments